Search results for: NHS Expenditure
Filter search results
The Cost of Drug Shortages
16 September 2024
…demonstrated that drug shortages can have huge impacts, differing across settings and drug types. Policymakers need to balance efforts to control pharmaceutical expenditure through cost-containment policies, with the downstream consequent…
Drug shortages are on the rise – but what is their impact?
16 September 2024
…by health systems. Policymakers need to weigh the control of expenditure against the cost of shortages. The costs to society of drug shortages are likely to be very large. Our…
The Trump Administration’s US Drug Pricing Proposal – What will happen next?
12 June 2025
…pharmaceutical industry (for example, via industry clawback schemes that cap medicines expenditure overall, like the voluntary scheme [VPAG] in the UK). Furthermore, the potential for higher revenue outside the US…
H.R. 3 is the Wrong Policy for the Wrong Problem
10 September 2021
…for the wrong problem. What is H.R. 3 and how would it work? As currently written, H.R. 3 would allow the government to cap the prices of certain high-expenditure prescription…
Pharmaceutical Innovation: Recent Trends, Future Prospects
1 October 1983
…morbidity still remaining in the community have provided a powerful incentive to continued investigation of the causes of, and potential solutions to, disease. As a consequence research expenditures have maintained…
The Inflation Reduction Act: Price negotiation underway for the first 10 drugs
29 November 2023
…selection include single-source drugs or biologics with the highest total Medicare Part B & D expenditures, approved by the FDA 7 or more (for small molecules) or 11 or more…
Forecasting the UK Medicines Bill to 2014
7 November 2011
…very likely to do so more slowly than before: 2.2% – 4.8% per year, compared to the 2005-09 growth rate of 5.3%. Primary care medicines expenditures in the UK NHS…
Implementing NICE Decisions in Wales: Opportunity Costs
10 June 2014
Just out is a new Research Paper from OHE that examines how local NHS organisations in Wales adjust spending to accommodate ‘shocks’ such as new NICE mandates for covering specific…
Can Transparency Lower Prices and Improve Access to Pharmaceuticals? Five Questions We Think Matter a Lot
29 March 2019
…which states “…there is limited context-specific evidence that improving price transparency has led to better price and expenditure outcomes. Nonetheless, improving price transparency should be encouraged on the grounds of…